No, Puracol collagen is not separately billable as a supply. It is classified as a dressing under HCPCS and is generally included in the overall service. However, the application of the product may be reportable using the appropriate CPT 1527X series code when it meets the definition of a skin substitute application.
Why This Matters
In wound care, collagen products often fall into a gray area between traditional dressings and more advanced biologic materials. That distinction directly impacts whether something can be billed separately or is considered included in the procedure.
Understanding how Puracol is classified per use helps avoid overbilling risks and documentation gaps, both of which are important for coding, billing, and compliance workflows.
Puracol is assigned HCPCS Level II codes like A6021 and A6022, which place it in the category of durable medical equipment, specifically dressings. That classification matters because dressings are typically not separately reportable when used as part of a wound care service.
At the same time, Puracol is a collagen-based product that supports healing by acting as a biological scaffold, which is conceptually similar to how skin substitutes function.
That’s where the nuance comes in.
CPT guidance for skin substitute grafts explains that these codes are intended for materials that provide a scaffold for skin growth, including human, non-human, and other biological products.
At the same time, CPT is very clear about what is not separately reportable, including:
- Gels, powders, ointments, foams, and liquids
- Non-graft wound dressings
- Routine wound cleansing or simple preparation
These types of supplies and services are considered part of the overall procedure.
So How Should You Bill It?
When Puracol is used, these are the key points:
- The product itself is not separately billable because it is classified as a dressing.
- The application may be billable if the documentation supports its use as a skin substitute (i.e., it is acting as scaffolding to encourage skin growth).
In other words, the reimbursement opportunity is tied to the procedure, not the supply.
Also keep in mind that when you report a skin substitute application code, the following steps are inherent to the procedure:
- Removal of any existing material
- Basic wound cleansing
- Placement of the new product
Practical Takeaway
- Report the CPT 1527X application code when documentation supports use as a scaffold-style application.
- Do not separately report A6021 or A6022 for the Puracol supply.
- Make sure documentation clearly reflects how the product is being used.
- Always check payer-specific guidance, as coverage policies can vary even when coding rules are consistent.
We hope this information helps guide your decision-making when determining how and when to bill Puracol use. Puracol is just one example of how collagen dressings can clinically function as a skin substitute. Clearly documenting the distinction when Puracol is used as a dressing or skin substitute helps ensure accurate coding and supports compliant reporting.
